Francesca Bersani

Author PubWeight™ 12.30^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation.	J Clin Invest	2009	2.36
2	Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma.	Cancer Res	2006	1.50
3	The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis.	Genes Dev	2013	0.98
4	RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis.	Cancer Gene Ther	2005	0.97
5	Conditional activation of MET in differentiated skeletal muscle induces atrophy.	J Biol Chem	2006	0.91
6	An in vivo model of Met-driven lymphoma as a tool to explore the therapeutic potential of Met inhibitors.	Clin Cancer Res	2008	0.85
7	The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes.	Exp Cell Res	2007	0.85
8	SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.	Cell Cycle	2015	0.83
9	Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces.	Langmuir	2013	0.79
10	Micro-orchestrating differentiation in cancer.	Cell Cycle	2010	0.79
11	Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.	PLoS One	2012	0.79
12	Differential expression of microRNA-206 in skeletal muscle of female Piedmontese and Friesian cattle.	Vet J	2011	0.79